System and Method for Intracochlear and Vestibular Magnetic Stimulation
Abstract
The United States medical device market approached $75 million USD last year. Cochlear Implants (CI) are devices that provide hearing aid to patients suffering from profound deafness or sensorineural hearing loss. CI’s have replaced the old hearing aid devices; and manufacturers are continually improving the quality and design of cochlear implants. During the last few years, there has been a significant increase in the demand for cochlear implants, and this has enhanced CI market growth. The global CI market is predicted to grow at a CAGR of 9.86% for five years, and is estimated to reach $3.2 billion USD by 2023.
Technology Summary
This technology entitled, “System and Method for Intracochlear and Vestibular Magnetic Stimulation” improves a devices sound fidelity and frequency sampling. It also circumvents inflammation-mediated sound quality reduction over time. As U.S. healthcare costs continue to rise, AU #2018-004’s quality improvements and lower production costs will make it very attractive to the major companies that operate in this space.
Auditory augmentation
• Localized cochlear stimulation
• No direct contact significantly reduces foreign body reactions (inflammation, scarring, reduced function over time)
• This CI model eliminates “cross talk”
• Lower production costs due to less expensive raw materials
由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。
provide hearing aid
sensorineural hearing loss
global ci market
vestibular magnetic stimulation
healthcare costs continue